Koers Jounce Therapeutics, Inc.
Aandelen
JNCE
US4811161011
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Michael Hearne
DFI | Director of Finance/CFO | - | - |
Eric Laub
IRC | Investor Relations Contact | - | 01-09-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - | |
0.00% | 18 M€ | +3,53% | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,30% | 102 mld. | |
+1,79% | 96,84 mld. | |
-0,44% | 21,48 mld. | |
-18,35% | 20,82 mld. | |
-7,45% | 18,6 mld. | |
-40,31% | 16,81 mld. | |
-26,84% | 13,78 mld. | |
+0,59% | 13,4 mld. | |
+20,86% | 11,06 mld. |